Menu
Back to Journals » OncoTargets and Therapy » Volume 7
Original Research
Therapeutic targeting of Neu1 sialidase with oseltamivir phosphate (Tamiflu®) disables cancer cell survival in human pancreatic cancer with acquired chemoresistance
| Total article views | Abstract views | HTML views | PDF downloads | Totals | |
|---|---|---|---|---|---|
| 10,666 | Dovepress* | 7,816 | 1,212+ | 1,688 | 9,028 |
| PubMed Central* | 7 | 1,631 | 450 | 1,638 | |
| Totals | 7,823 | 2,843 | 2,138 | 10,666 | |
|
*Since 16 January 2014 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 6 | 0 | 0 | 0 | 3 | 3 |
View citations on PubMed Central and Google Scholar